LCCDEs miR-21 and miR-29a can activate Toll-like receptors 7 (TLR7) and 8 (TLR8) on immune cells to activate NFκB and prometastatic inflammatory response, ultimately leading to tumor growth and metastasis [120]. Here, TLR7 is linked to neoplasm.